Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye

NANot yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

December 15, 2026

Study Completion Date

December 15, 2026

Conditions
Dry Eye Syndromes
Interventions
OTHER

Platelet Poor Plasma Tear Drops

Participant blood will be drawn and processed by the University of Rochester Transfusion Medicine and Blood Bank. Processing will isolate the platelet free fraction of the blood plasma. After processing, plasma should contain ≤ 5% concentration of white blood cells (WBC), red blood cells (RBC), and platelets when compared to the concentration before processing.

OTHER

Platelet Rich Plasma Tear Drops

Participant blood will be drawn and processed by the University of Rochester Transfusion Medicine and Blood Bank. Processing will isolate the platelet fraction of the blood plasma. After processing, plasma should contain ≤ 5% concentration of WBC and RBC and 100 x 10³ μl or ≥ 50% recovery of platelets when compared to the pre-platelet count.

Trial Locations (1)

14642

Flaum Eye Institute at the University of Rochester, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER

NCT05121493 - Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye | Biotech Hunter | Biotech Hunter